The life science investment firm Bioluminescence Ventures will close its doors less than two years after its founding, despite raising nearly half a billion dollars
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical business to Bain Capital in a carve-out worth about $3.3 billion. The deal comes after Japan
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
→ Francisco Ballester is retiring as president, region international at Sandoz on March 1, and Peter Stenico will replace him. Ballester has held this role
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Almost 16 years after Rituxan’s disappointing data in lupus, Roche’s Genentech found success with a different B cell-killing drug called Gazyva in lupus nephritis …
LOS ANGELES — For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive intra-arterial (IA) thrombolytics work to improve outcomes after
Geographic atrophy (GA) progressed more often in patients with better baseline vision and those with lesions closer to the foveal center, according to a study
When added to standard care, more lupus nephritis patients achieved complete remissions with obinutuzumab (Gazyva) than with placebo. Treatment was added to mycophenolate mofetil and
Three Democratic states sued the Trump administration on Friday over its order to ban federal funding for gender-affirming care for transgender people under 19. Washington